Assessing risk and improving survival in lymphoma

Affiliations

Editorial

Paul A Fields et al. Br J Gen Pract. 2015 May.

. 2015 May;65(634):220-1.

doi: 10.3399/bjgp15X684661.

No abstract available

Figures

Quantifying the risk of non-Hodgkin lymphoma in symptomatic primary care patients aged ≥40 years: a large case-control study using electronic records.
Shephard EA, Neal RD, Rose PW, Walter FM, Hamilton WT. Shephard EA, et al. Br J Gen Pract. 2015 May;65(634):e281-8. doi: 10.3399/bjgp15X684793. Br J Gen Pract. 2015. PMID: 25918332 Free PMC article.
Quantifying the risk of Hodgkin lymphoma in symptomatic primary care patients aged ≥40 years: a case-control study using electronic records.
Shephard EA, Neal RD, Rose PW, Walter FM, Hamilton WT. Shephard EA, et al. Br J Gen Pract. 2015 May;65(634):e289-94. doi: 10.3399/bjgp15X684805. Br J Gen Pract. 2015. PMID: 25918333 Free PMC article.

1. Cancer Research UK Non-Hodgkin lymphoma (NHL) key stats. http://www.cancerresearchuk.org/cancer-info/cancerstats/keyfacts/non-hod... (accessed 10 Apr 2015)
1. Cancer Research UK Hodgkin lymphoma statistics. http://www.cancerresearchuk.org/cancer-info/cancerstats/types/hodgkinsly... (accessed 10 Apr 2015)
1. Morton LM, Wang SS, Devesa SS, et al. Lymphoma incidence patterns by WHO subtype in the United States, 1992–2001. Blood. 2006;107(1):265–276. Epub 2005/09/10. - PMC - PubMed
1. Sant M, Minicozzi P, Mounier M, et al. Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE–5, a population-based study. Lancet Oncol. 2014;15(9):931–942. - PubMed
1. De Angelis R, Sant M, Coleman MP, et al. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE–5 — a population-based study. Lancet Oncol. 2014;15(1):23–34. - PubMed